Please provide your email address to receive an email when new articles are posted on . The costs of epinephrine autoinjectors have decreased since generic options arrived in 2016, but these costs ...

CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...

NASHVILLE, Tenn. (WKRN) – – The U.S. Food and Drug Administration approved the first generic version of the EpiPen. Teva Pharmaceuticals USA gained approval to market its generic epinephrine ...

EWING, N.J., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that the U.S. Food and Drug Administration (FDA ...

The FDA cleared the first generic version of EpiPen and EpiPen Jr, an epinephrine auto-injector for severe allergic reactions, 2 years after generic drugmaker Teva Pharmaceuticals was first turned ...

* Mylan says authorized generic, which will reach pharmacies starting next week, has same drug formulation and device functionality as Epipen auto-injector Sign up here. * Authorized generic for ...

Generic would cost about half the current $600 price for set of two. Mylan Inc., the company that makes EpiPen, has come under fire from consumers and lawmakers for the price it is currently charging ...

People with severe allergies now have more choices for which epinephrine auto-injector to carry in case they suffer a life-threatening attack, and most pay less for it than they did when the EpiPen ...

As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...

Dublin, April 30, 2020 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injector Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The Global ...

Getting your Trinity Audio player ready... A bill in the Colorado legislature would allow stiffer penalties for EpiPen and insulin manufacturers who refuse to sell their products under the state’s ...